Ratio Revelations: Alignment Healthcare Inc (ALHC)’s Financial Metrics in the Spotlight

Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.

Alignment Healthcare Inc (NASDAQ: ALHC) closed the day trading at $6.83 down -1.16% from the previous closing price of $6.91. In other words, the price has decreased by -$1.16 from its previous closing price. On the day, 1.12 million shares were traded. ALHC stock price reached its highest trading level at $6.95 during the session, while it also had its lowest trading level at $6.6901.


For a better understanding of ALHC, let’s look at its different ratios. In the meantime, Its Debt-to-Equity ratio is 1.30 whereas as Long-Term Debt/Eq ratio is at 1.30.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Piper Sandler on May 08, 2024, Upgraded its rating to Overweight and sets its target price to $8 from $6 previously.

On March 06, 2024, Barclays started tracking the stock assigning a Underweight rating and target price of $4.50.

Piper Sandler Downgraded its Overweight to Neutral on March 06, 2024, whereas the target price for the stock was revised from $12 to $6.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 28 ’24 when Maroney Dawn Christine sold 10,151 shares for $4.84 per share. The transaction valued at 49,131 led to the insider holds 1,976,097 shares of the business.

Kardes Hakan sold 4,363 shares of ALHC for $21,117 on Mar 28 ’24. The Chief Experience Officer now owns 430,444 shares after completing the transaction at $4.84 per share. On Mar 28 ’24, another insider, Freeman Robert Thomas, who serves as the Chief Financial Officer of the company, sold 4,299 shares for $4.84 each. As a result, the insider received 20,807 and left with 865,407 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALHC now has a Market Capitalization of 1305882368 and an Enterprise Value of 1175729152. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.65 while its Price-to-Book (P/B) ratio in mrq is 9.97. Its current Enterprise Value per Revenue stands at 0.584 whereas that against EBITDA is -10.515.

Stock Price History:

The Beta on a monthly basis for ALHC is 1.33, which has changed by 0.0058909655 over the last 52 weeks, in comparison to a change of 0.26265144 over the same period for the S&P500. Over the past 52 weeks, ALHC has reached a high of $9.20, while it has fallen to a 52-week low of $4.46. The 50-Day Moving Average of the stock is 31.52%, while the 200-Day Moving Average is calculated to be 5.60%.

Shares Statistics:

Over the past 3-months, ALHC traded about 1.03M shares per day on average, while over the past 10 days, ALHC traded about 1395020 shares per day. A total of 188.95M shares are outstanding, with a floating share count of 90.98M. Insiders hold about 52.41% of the company’s shares, while institutions hold 40.02% stake in the company. Shares short for ALHC as of 1714435200 were 5991224 with a Short Ratio of 5.83, compared to 1711584000 on 3944667. Therefore, it implies a Short% of Shares Outstanding of 5991224 and a Short% of Float of 4.9000002.

Earnings Estimates

At present, 10.0 analysts are actively evaluating the performance of Alignment Healthcare Inc (ALHC) in the stock market.On average, analysts expect EPS of -$0.14 for the current quarter, with a high estimate of -$0.08 and a low estimate of -$0.16, while EPS last year was -$0.15. The consensus estimate for the next quarter is -$0.1, with high estimates of -$0.02 and low estimates of -$0.14.

Analysts are recommending an EPS of between -$0.3 and -$0.74 for the fiscal current year, implying an average EPS of -$0.65. EPS for the following year is -$0.52, with 10.0 analysts recommending between -$0.21 and -$0.71.

Revenue Estimates

9 analysts predict $631.02M in revenue for the current quarter. It ranges from a high estimate of $644.01M to a low estimate of $604M. As of the current estimate, Alignment Healthcare Inc’s year-ago sales were $439.03MFor the next quarter, 9 analysts are estimating revenue of $625.46M. There is a high estimate of $635.26M for the next quarter, whereas the lowest estimate is $604M.

A total of 10 analysts have provided revenue estimates for ALHC’s current fiscal year. The highest revenue estimate was $2.55B, while the lowest revenue estimate was $2.5B, resulting in an average revenue estimate of $2.52B. In the same quarter a year ago, actual revenue was $1.82BBased on 10 analysts’ estimates, the company’s revenue will be $3.1B in the next fiscal year. The high estimate is $3.37B and the low estimate is $3B.

Most Popular

[the_ad id="945"]